EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

IGF2BP2 Drives Cell Cycle Progression in Triple‐Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A‐Modified CDK6 Translation Initiation Process

Tian Xia iD, Xin-Yuan Dai, Ming-Yi Sang, Xu Zhang, Feng Xu, Jing Wu, Liang Shi, Ji-Fu Wei, Qiang Ding iD

Advanced Science · 2024-01 · 11 (1)

DOI: 10.1002/advs.202305142 ↗

At a glance

Journal article in Advanced Science, published online on 2023-11-20. Written by Tian Xia and 8 co-authors. Institution: Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China. Major MEDLINE topics: Triple Negative Breast Neoplasms. Cited 51 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Project of Changzhou Medical Center.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

IGF2BP2 is a new identified N6‐methyladenosine (m6A) reader and associated with poor prognosis in many tumors. However, its role and related mechanism in breast cancer, especially in triple‐negative breast cancer (TNBC), remains unclear. In this study, it is found that IGF2BP2 is highly expressed in TNBC due to the lower methylation level in its promoter region. Functional and mechanical studies displayed that IGF2BP2 could promote TNBC proliferation and the G1/S phase transition of the cell cycle via directly regulating CDK6 in an m6A‐dependent manner. Surprising, the regulation of protein levels of CDK6 by IGF2BP2 is related to the changes in translation rate during translation initiation, rather than mRNA stability. Moreover, EIF4A1 is found to be recruited by IGF2BP2 to promote the translation output of CDK6, providing new evidence for a regulatory role of IGF2BP2 between m6A methylation and translation. Downregulation of IGF2BP2 in TNBC cell could enhance the sensitivity to abemaciclib, a CDK4/6 inhibitor. To sum up, our study revealed IGF2BP2 could facilitate the translation output of CDK6 via recruiting EIF4A1 and also provided a potential therapeutic target for the diagnosis and treatment of TNBC, as well as a new strategy for broadening the drug indications for CDK4/6 inhibitors.

Subjects

MeSH terms (MEDLINE)

Triple Negative Breast NeoplasmsHumansCell CycleDown-RegulationRNA StabilityRNA-Binding ProteinsCyclin-Dependent Kinase 6Adenine

Author keywords

CDK6Cell cycleIGF2BP2N6-methyladenosine (m6A)

Substances

RNA-Binding ProteinsCyclin-Dependent Kinase 6IGF2BP2 protein, humanCDK6 protein, human6-methyladenineAdenine

Authors and institutions

  • Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
  • Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210029, China.

ORCID profiles: Tian Xia, Qiang Ding

Funding

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Project of Changzhou Medical Center
  • Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University

Cite

APA

Xia, T., Dai, X. Y., Sang, M. Y., Zhang, X., Xu, F., Wu, J., Shi, L., Wei, J. F., & Ding, Q. (2024). IGF2BP2 Drives Cell Cycle Progression in Triple‐Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A‐Modified CDK6 Translation Initiation Process. Advanced Science, 11(1). https://doi.org/10.1002/advs.202305142

Vancouver

Xia T, Dai XY, Sang MY, Zhang X, Xu F, Wu J, et al. IGF2BP2 Drives Cell Cycle Progression in Triple‐Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A‐Modified CDK6 Translation Initiation Process. Advanced Science. 2024;11(1). doi:10.1002/advs.202305142

BibTeX
@article{Xia2024,
  author = {Xia, Tian and Dai, Xin-Yuan and Sang, Ming-Yi and Zhang, Xu and Xu, Feng and Wu, Jing and Shi, Liang and Wei, Ji-Fu and Ding, Qiang},
  title = {IGF2BP2 Drives Cell Cycle Progression in Triple‐Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A‐Modified CDK6 Translation Initiation Process},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {1},
  doi = {10.1002/advs.202305142}
}
Start for free →